cota-logo-wht-rgb
Contact Us
cota-logo-wht-rgb
cota-pattern

Bringing clarity to cancer

We are working to ensure that everyone touched by cancer has a clear path to the right care.
cota-pattern

Our Approach

We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.

Together, we can bring clarity to cancer care.

#6846 - COTA Healthcare homepage redesign - Providers

Providers

We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.

#6846 - COTA Healthcare homepage redesign - Payers

Payers

We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.

#6846 - COTA Healthcare homepage redesign - Life Sciences

Life Sciences

Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.

The Importance of Diversity in the Medical Research Workforce with Esther Krofah

In today’s Real World Talk podcast episode, our host Zoe Li welcomes Esther Krofah, the Executive Director at FasterCures. Esther talks about the lessons they as an organization have learned during the pandemic. She also discusses the importance of real world-data and says, although all studies start in a controlled environment, authentic results come when trials are applied to real-world settings.
Watch the episode
COTA Survey Report

Study: Cancer Patients and Their Families Frustrated with Slow Pace of Drug and Treatment Innovation

COTA announced findings from a study that found 66% of cancer patients and families surveyed think the speed of clinical trials for cancer treatments remains far too slow. Read more of the findings from the study, which surveyed 1,110 Americans who’ve either had cancer or who’ve had someone in their immediate family with cancer.

READ MORE

Latest Resources

COTA and MedStar Health Partner To Drive Scientific Research and Expedite Delivery of Innovative Cancer Treatments

MedStar Health — the largest healthcare provider in the Maryland and Washington, D.C., region — will leverage COTA’s real-world data expertise to deliver more precise care for cancer patients
read more

COTA and University of Chicago Medicine Collaborate To Study Racial Disparities in Cancer Treatment

COTA, Inc., an oncology real-world data and analytics company, and University of Chicago Medicine announced a research collaboration agreement to investigate racial disparities of care in multiple myeloma to better understand differences in the diagnosis, treatment patterns, and outcomes of patients with this type of cancer.
read more

The Importance of Real World Data in Oncology Research with Donna Rivera

In this episode of the Real World Talk podcast, our host Drew Belli introduces Donna Rivera, the Associate Director for Pharmacoepidemiology, RWD & RWE at FDA Oncology Center of Excellence. Donna is a pharmacist and pharmacoepidemiologist with over ten years of clinical pharmacy, data science, and research expertise across government, academia, and industry enterprise. She’s passionate about cultivating collaborations that facilitate real-world data (RWD) transformation into real-world evidence (RWE) in Oncology to meaningfully improve drug development and outcomes for patients.
listen now

Let’s work together to transform cancer care.

REQUEST A DEMO

Bringing clarity to cancer

We are working to ensure that everyone touched by cancer has a clear path to the right care.

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.